The limitations of our study include a small patient cohort and relatively broad exclusion criteria, which encompassed active neoplastic processes or paraneoplastic syndromes, diagnosed active viral or bacterial infections, chronic kidney disease (stages III-V), an elevated erythrocyte sedimentation rate, and serum CRP levels. The gene discussed is CRP; the disease is bacterial infectious disease.